↓ Skip to main content

Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial

Overview of attention for article published in Trials, November 2020
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
201 Mendeley
Title
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
Published in
Trials, November 2020
DOI 10.1186/s13063-020-04839-5
Pubmed ID
Authors

Shaukat Ali, Shobha Luxmi, Fatima Anjum, Sheikh Muhammad Muhaymin, Syed Muneeb Uddin, Ayesha Ali, Mir Rashid Ali, Sohaib Tauheed, Mujtaba Khan, Mohsin Bajwa, Saif Ullah Baig, Elisha Shalim, Iqra Ahmed, Abdul Samad Khan, Saeed Quraishy

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 201 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 201 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 10%
Student > Bachelor 19 9%
Other 17 8%
Researcher 15 7%
Student > Ph. D. Student 12 6%
Other 39 19%
Unknown 78 39%
Readers by discipline Count As %
Medicine and Dentistry 55 27%
Nursing and Health Professions 25 12%
Social Sciences 7 3%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Psychology 4 2%
Other 16 8%
Unknown 87 43%